Yanaika S. Hin
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.
Journal: Nature aging
Published: January 05, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.
Journal: Nature medicine
Published: November 18, 2025
Microglia protein profiles in CSF across Alzheimer's disease clinical stages.
Journal: Nature aging
Published: June 02, 2025
Development and validation of a novel panel of CSF biomarkers for Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: April 25, 2025
CHIT1 and DDAH1 levels relate to amyloid-related imaging abnormalities risk profile in Alzheimer's disease patients.
Journal: Alzheimer's research & therapy
Published: April 11, 2025
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders.
Journal: Nature medicine
Published: March 21, 2025
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia.
Journal: Molecular neurodegeneration
Published: November 13, 2024
Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of Frontotemporal Dementia.
Journal: medRxiv : the preprint server for health sciences
Published: September 04, 2024
CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals.
Journal: Molecular neurodegeneration
Published: April 20, 2024
Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.
Journal: Brain : a journal of neurology
Published: September 04, 2023
Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross-platform validation study.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: April 25, 2023
CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
CSF proteomics in autosomal dominant Alzheimer's disease highlights parallels with sporadic disease.
Journal: Brain : a journal of neurology
Published: January 24, 2023
Last Updated: 09/26/2026